GlassScriptPhysician profile
Jennifer L Kohn
NPI 1457512782
$2,583.07
in general payments reported to CMS, 2019-2025
16 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $66.30 · 2021: $207 · 2022: $204 · 2023: $542 · 2024: $531 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $175 · Entertainment: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $175.00 |
| Entertainment | $133.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $509.03 | 2023-2025 | Infuse, Infuse Multifocal, Revive |
| Coopervision INC. | $323.09 | 2022-2024 | Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $288.17 | 2022-2025 | Total30, Tryptyr, Precision 1 |
| Optos, INC. | $237.05 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $205.91 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $191.30 | 2019-2020 | |
| Dompe US, INC. | $153.58 | 2024-2025 | Oxervate |
| Shire North American Group INC | $124.99 | 2019 | |
| Oyster Point Pharma, INC. | $122.82 | 2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $105.08 | 2024 | |
| Abb Con-Cise Optical Group LLC | $102.43 | 2021 | |
| Maculogix, INC. | $100.04 | 2019 | |
| Rxsight INC | $41.76 | 2022 | |
| Glaukos Corporation | $36.68 | 2019 | |
| Abbvie INC. | $22.42 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.72 | 2025 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Kohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.